Release The Power Of Precise Proteomics

Accelerating proteomics-driven precision medicine

Precision Biomarker Laboratories, a commercial contract research organization (CRO) wholly owned by Cedars-Sinai Medical Center, provides complete proteomics solutions across biomarker discovery, validation and CAP/CLIA-certified laboratory testing capabilities.  Our customized workflows allow for the quick translation from protein discovery to clinically validated targeted panels.

The proteome is a dynamic indicator of health

Unlike the genome, the proteome changes over time and throughout the life builds up a tremendous complexity. From around 22000 human genes, more than a million proteoforms are translated, forming a dynamic pool of indicators for health and illness.

The proteome not only serves as a signature of current physiological status in response to multiple change triggers and perturbations, but also offers relevant insights into targets for therapeutic intervention.

Proteomics provides valuable data:

Analyzing the proteome provides multiple layers of information about proteins like expression, function, structure, subcellular location, post-translational modifications (PTMs) and protein-protein interactions.

Combining layers of proteome knowledge reveal insights into:

  • Impact of disease triggers
  • Mechanism of a disease
  • Treatment opportunities and intervention

Accelerate your breakthrough
drugs and diagnostics

Drug Discovery

  • Discover the right target for your next breakthrough drug with quick and precise delivery of results
  • Fast go/no-go decisions at any development step
  • Customized and fully integrated solutions to support your asset launch goal

  • Our integrated proteomics workflows are designed to accelerate the drug discovery process and maximize the development success.

    Pre-Clinical Studies

  • Proteome-wide target identification, characterization, and validation from all sample types
  • Clinical infrastructure and expertise to establish biomarker validity
  • Custom and flexible workflows to optimize chances of clinical trial success

  • Robust workflows are available across all types of biological samples, including blood, plasma, cells, tissue, and other physiological fluids.


  • Discovery of novel biomarkers for diagnosing and predicting disease progression
  • Customized multi-biomarker panel development for faster clinical decisions
  • GLP and CAP/CLIA-certified laboratory capabilities

  • Precision Biomarker Laboratories delivers quantitative proteomics data with high-precision, depth, and reproducibility.

    Our Services

    Discovery Proteomics

    Revealing the whole proteome through deep protein profiling and quantification of thousands of proteins from various sample types (blood, plasma, cells, tissues, and other physiological fluids).

    Targeted Proteomics

    Target protein detection and validation with high sensitivity, specificity, reproducibility and quantitative accuracy. Powered by mass spectrometry and immunoassay technologies: Olink®, Quanterix™ and Meso Scale Discovery.

    Translational Proteomics

    Amplifying the value of proteomics with customized biomarker panels, for faster clinical decisions and drug development.

    Let's connect

    Discuss and plan your next project with our talented team of proteomics experts!